Departamento de Cirugía, Fundación Valle del Lili, Avenida Simón Bolivar, Carrera 98 Número 18-49, Cali, Colombia.
World J Surg. 2012 Dec;36(12):2761-6. doi: 10.1007/s00268-012-1745-3.
Abdominal packing (AP) in damage-control laparotomy (DCL) is a lifesaving technique that controls coagulopathic hemorrhage in severely injured trauma patients. However, the impact of the duration of AP on the incidence of re-bleeding and on intra-abdominal infections in penetrating abdominal trauma is not clear. The objective of the present study was to evaluate the complications related to the duration of AP and to determine the optimal time for AP removal.
Prospectively collected/retrospectively analyzed data at an urban level I trauma center from January 2003 to December 2010 were used as the basis for this study. Inclusion criteria were adults (≥18 years old) with penetrating abdominal trauma, who had survived both the initial DCL procedure and their first re-laparotomy. All initial DCL patients included in the study underwent abdominal packing for coagulopathic hemorrhage control. The outcome measures of this study were re-bleeding after packing removal, intra-abdominal infection, and 30-day cumulative mortality. We considered time after packing as an independent variable. This was defined as the total amount of time (in days) that the packs were left in the patient's abdomen. Patients were grouped according to the duration in days of their AP in <1, 1-2, 2-3, and >3 days.
Of 503 patients with penetrating abdominal trauma, 121 underwent DCL and AP. The mean age was 30.1± 11.5 years, and the male to female ratio was 9:1. The mean Acute Physiology and Chronic Health Evaluation (APACHE II) score was 17.6±7.2. The mean Injury Severity Score (ISS) score was 24.9±9.1. The right upper quadrant was packed in 39 (32.2%) patients, retroperitoneum in 70 (57.8%), pelvis in 13 (10.7%), and left upper quadrant in 9 (7.4%). Fifty-one patients (42.1%) had associated colon injuries and 58 (47.9%) had small bowel injuries. Twenty-six patients (21.5%) had AP<1 day, 42 patients (34.7%) had AP between 1 and 2 days, 35 patients (28.9%) had AP between 2 and 3 days, and 18 patients (14.8%) had AP>3 days. The re-bleeding rate in patients packed for 1-2 days compared to those packed for <1 day was a third lower, 14.3%, (95% confidence interval [95% CI]: 8.06, 20.5) versus 38.5% (95% CI: 25.4, 51.5). Conversely, an increasing trend toward intra-abdominal infection occurred as time after packing increased. The infection rate tripled from 16.7% (95% CI: 6.6, 26.7) to 44.4% (95% CI: 31.03, 57.7) when comparing 1-2 days versus >3 days. Overall mortality was 16.5%. Of these deaths, 8.26% were attributable to re-bleeding, and 13.2% to intra-abdominal infection. Deaths secondary to re-bleeding seemed to decrease with time of AP, whereas intra-abdominal infection deaths increased with time of AP (Chi square for trend p value=0.04).
The present study suggests that AP used in the setting of DCL for coagulopathic hemorrhage control should not be removed prior to the first postoperative day because of the increased risk of re-bleeding. The ideal length of AP is 2-3 days, and AP left in longer than 3 days is associated with a significantly increased risk of infectious complications.
在损伤控制性剖腹术中(DCL)中使用腹部填塞(AP)是控制严重创伤患者凝血功能障碍性出血的救命技术。然而,AP 持续时间对再出血发生率和穿透性腹部创伤的腹腔内感染的影响尚不清楚。本研究的目的是评估与 AP 持续时间相关的并发症,并确定 AP 去除的最佳时间。
本研究使用 2003 年 1 月至 2010 年 12 月在城市一级创伤中心前瞻性收集/回顾性分析的数据作为基础。纳入标准为成人(≥18 岁),有穿透性腹部创伤,在初始 DCL 手术后和第一次再次剖腹手术后均存活。所有纳入研究的初始 DCL 患者均因凝血功能障碍性出血控制而行腹部填塞。本研究的结局指标为填塞去除后的再出血、腹腔内感染和 30 天累积死亡率。我们将时间作为独立变量。这被定义为填塞物在患者腹部中的总时间(以天数计)。根据 AP 的持续时间将患者分为<1 天、1-2 天、2-3 天和>3 天。
在 503 例穿透性腹部创伤患者中,121 例接受了 DCL 和 AP。平均年龄为 30.1±11.5 岁,男女比例为 9:1。平均急性生理学和慢性健康评估(APACHE II)评分为 17.6±7.2。平均损伤严重程度评分(ISS)为 24.9±9.1。右上象限填塞 39 例(32.2%),后腹膜填塞 70 例(57.8%),骨盆填塞 13 例(10.7%),左上象限填塞 9 例(7.4%)。51 例(42.1%)患者有结肠合并伤,58 例(47.9%)患者有小肠合并伤。26 例(21.5%)AP<1 天,42 例(34.7%)AP 为 1-2 天,35 例(28.9%)AP 为 2-3 天,18 例(14.8%)AP>3 天。与 AP<1 天相比,AP 持续时间为 1-2 天的患者再出血率降低三分之一,为 14.3%(95%置信区间 [95%CI]:8.06,20.5),而 38.5%(95%CI:25.4,51.5)。相反,随着填塞后时间的增加,腹腔内感染的发生率呈上升趋势。1-2 天与>3 天相比,感染率增加了两倍,从 16.7%(95%CI:6.6,26.7)增加到 44.4%(95%CI:31.03,57.7)。总死亡率为 16.5%。其中,8.26%的死亡归因于再出血,13.2%归因于腹腔内感染。继发于再出血的死亡似乎随着 AP 的时间而减少,而继发于腹腔内感染的死亡随着 AP 的时间而增加(趋势检验的 χ 平方检验 p 值=0.04)。
本研究表明,在 DCL 中使用 AP 控制凝血功能障碍性出血时,由于再出血的风险增加,不应在术后第一天之前去除。AP 的理想长度为 2-3 天,AP 持续时间超过 3 天与感染性并发症的风险显著增加相关。